Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2014
08/14/2014US20140228379 Pyrido-Pyrimidine Derivatives
08/14/2014US20140228376 Heterocyclic Compounds for the Treatment of CF
08/14/2014US20140228370 Substituted imidazopyridazines
08/14/2014US20140228363 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
08/14/2014US20140228361 Aminoquinazoline derivatives and their salts and methods of use
08/14/2014US20140228359 Bis-indolic derivatives, their uses in particular as antibacterials
08/14/2014US20140228350 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
08/14/2014US20140228340 Benzonitrile derivatives as kinase inhibitors
08/14/2014US20140228331 Compositions of protein receptor tyrosine kinase inhibitors
08/14/2014US20140228323 Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
08/14/2014US20140228307 Composition and method for treating an autoimmune disease
08/14/2014US20140228300 Methods for modulating factor 12 expression
08/14/2014US20140228290 Compositions and methods of treating cancer
08/14/2014US20140228287 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-axanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
08/14/2014US20140228286 Specific pde4b-inhibitors for the treatment of diabetes mellitus
08/14/2014US20140228284 Pharmaceutical compositions
08/14/2014US20140228283 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
08/14/2014US20140227376 Methods and Compositions for Enhancing Hair Quality Using Blackberry Extract
08/14/2014US20140227375 PIP-2 Inhibition-Based Antiviral and Anti-Hyperlipidemic Therapies
08/14/2014US20140227352 Oral aphrodisiac herbal composition and capsule
08/14/2014US20140227348 Peptides that target dorsal root ganglion neurons
08/14/2014US20140227341 Methods of using regenerative cells to promote wound healing
08/14/2014US20140227339 Regenerative tissue grafts and methods of making same
08/14/2014US20140227335 Virucidal small molecule and uses thereof
08/14/2014US20140227308 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
08/14/2014US20140227302 Gamma secretase inhibitors
08/14/2014US20140227294 Prolactin receptor binding proteins and uses thereof
08/14/2014US20140227284 Synthetic lethality and the treatment of cancer
08/14/2014US20140227279 Methods and compositions for the treatment of autoimmune and inflammatory diseases
08/14/2014US20140227278 Antibodies to human signal peptide-containing proteins
08/14/2014US20140227260 Aminopyrimidine inhibitors of tyrosine kinase
08/14/2014US20140227254 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
08/14/2014US20140227247 Chimeric neuregulins and method of making and use thereof
08/14/2014US20140227237 Rna engineered t cells for the treatment of cancer
08/14/2014US20140227234 Methods of using regenerative cells to promote wound healing
08/14/2014US20140227231 Laminins, derivatives, and compositions including same and methods for their therapeutic use
08/14/2014US20140227226 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
08/14/2014US20140227225 HCV Helicase Inhibitors and Methods of Use Thereof
08/14/2014US20140227224 Salts of hiv inhibitor compounds
08/14/2014US20140227222 Cyclin dependent kinase inhibitors and methods of use
08/14/2014US20140227221 Methods of treating multiple myeloma and resistant cancers
08/14/2014US20140227219 Compositions and Methods Comprising BMP-7
08/14/2014US20140227214 Protection Against Sunburn And Skin Problems With Topical And Orally-Ingested Dosages of Zeaxanthin
08/14/2014US20140227208 Cosmetic compositions containing substituted azole and methods for alleviating mechanically-induced skin inflammation
08/14/2014US20140227207 Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
08/14/2014US20140227198 Shelf-stable olive extract-containing compositions and methods of use thereof
08/14/2014US20140227194 Preparation for Restenosis Prevention
08/14/2014US20140227193 Preparation for Restenosis Prevention
08/14/2014US20140227192 Preparation for Restenosis Prevention
08/14/2014US20140227188 Compositions and Methods for Using Cathepsin E Cleavable Substrates
08/14/2014US20140227185 Glutathione-based drug delivery system
08/14/2014US20140227180 Antibody-sn-38 immunoconjugates with a cl2a linker
08/14/2014US20140227179 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/14/2014US20140227178 Humanized Anti-HLA-DR Antibodies
08/14/2014US20140227173 Cancer treatment with gamma-secretase inhibitors
08/14/2014US20140227172 Diagnosis and treatment of prostate cancer
08/14/2014US20140224692 Therapeutic rinse
08/13/2014EP2764874A1 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic stem cells and uses thereof
08/13/2014EP2764873A1 Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound
08/13/2014EP2764871A1 Methods for the prevention or treatment of heart failure
08/13/2014EP2764865A2 Cancer treatment
08/13/2014EP2763670A1 Reactivation of hiv-1 gene expression to treat persistent hiv infection
08/13/2014CN103981198A 人非小细胞肺癌中的易位和突变的ros激酶 Human non-small cell lung cancer translocations and mutations in the kinase ros
08/13/2014CN103980353A 一种疏水蛋白及其组成的药物制剂 Consisting of a hydrophobic protein and its pharmaceutical preparations
08/13/2014CN103977434A 一种对羟基苯甲酸介导的脑靶向聚合物胶束递药系统 A kind of brain-hydroxy acid-mediated drug delivery systems targeted polymeric micelles
08/13/2014CN103977425A 一种检测和评价分子和药物生物学功能的方法及其用途 A method for detecting and evaluating the biological function of the drug molecule and the method of its use
08/13/2014CN103977409A 一种膳食补充剂组合物及其用于调控血糖的方法 Method and a dietary supplement composition for modulating blood sugar
08/13/2014CN103977408A 整合素α<sub>M</sub>β<sub>2</sub>的拮抗剂在制备治疗血小板数量相关疾病的药物中的应用 Integrin α <sub> M </ sub> β <sub> 2 </ sub> antagonists used in the preparation of the treatment of diseases related to platelet counts in
08/13/2014CN103977407A 一种供口服纳米粒多肽组合物片剂及其制备方法 An oral nanoparticles polypeptide composition and preparation method for a tablet
08/13/2014CN103977406A 抗病毒化合物 Antiviral compounds
08/13/2014CN103977405A N-2-羟基-乙基-哌嗪-n'-2-乙磺酸(hepes)在疼痛控制和脱髓鞘损伤逆转中的作用 N-2- hydroxy - ethyl - piperazine -n'-2- ethanesulfonic acid (hepes) in reversal of pain control and demyelinating injury
08/13/2014CN103977403A 治疗溶血性疾病的方法 A method of treating a hemolytic disease
08/13/2014CN103977003A 用于降低治疗的副作用的方法和组合物 A method for reducing the side effects of treatment and compositions
08/13/2014CN103127508B 一种含有泽兰治疗畜禽大肠杆菌感染疾病的复方组合物 E. coli containing Zeeland treat infectious diseases of livestock and poultry compound composition
08/13/2014CN102847151B 含有巯乙基磺酸钠和糖皮质激素的吸入制剂及其制备方法 Mercaptoethyl sodium and inhaled corticosteroids containing its preparation method
08/13/2014CN102631689B 一种用于诊疗的磁共振成像造影剂及其制备方法 A magnetic resonance imaging contrast agent treatment and preparation methods for
08/13/2014CN102365550B 口腔组合物的抗骨丢失和抗附着丧失作用 The oral composition of bone loss and anti-anti-adhesion effect of the loss of
08/13/2014CN101987198B 药物组合物 The pharmaceutical composition of
08/13/2014CN101897711B 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 Containing the HMG-CoA reductase inhibitors, aspirin, folic acid, nicotinic acid pharmaceutical composition and use thereof
08/13/2014CN101861151B 使用组蛋白脱乙酰基酶hdac1、hdac2和/或hdac3的选择性抑制剂和微管稳定剂的癌症组合治疗 The use of histone deacetylase hdac1, hdac2 and cancer combination therapy / or hdac3 selective inhibitors and microtubule stabilizer
08/12/2014US8802826 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
08/12/2014US8802736 High concentration capsaicinoid pain relief composition
08/12/2014US8802717 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
08/12/2014US8802715 Crystal forms of saxagliptin and processes for preparing same
08/12/2014US8802701 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
08/12/2014US8802699 Quinuclidine derivatives and medicinal compositions containing the same
08/12/2014US8802667 Benzodiazepine derivatives
08/12/2014US8802158 Methods of use of probiotic Lactobacilli for companion animals
08/12/2014US8802152 Microporous zirconium silicate for the treatment of hyperkalemia
08/12/2014US8802147 Controlled release of biologically active compounds
08/12/2014US8802139 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
08/12/2014US8802117 Melatonin and immunostimulating substance-based compositions
08/12/2014US8802114 Pharmaceutical compositions of iron for oral administration
08/12/2014US8802092 Mesothelioma therapeutic agent
08/12/2014US8802078 Compositions and methods for modifying a silicone surface for prolonged interference against pathogen colonization
08/12/2014CA2629312C Compositions and methods for treating cns disorders
08/12/2014CA2551813C Compositions and methods for the treatment of tumor of hematopoietic origin
08/12/2014CA2543255C Methods and compositions for regenerating connective tissue
08/12/2014CA2343223C Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/07/2014US20140221497 Methods of Using Rapid-Onset Selective Serotonin Reuptake Inhibitors for Treating Sexual Dysfunction
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 1151